Clinical Trial Update: Losartan Therapy in Pulmonary Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating losartan for pulmonary hypertension has completed; the update does not report results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Baskent University | Conditions: Pulmonary Hypertension | Phase 3 | Status: COMPLETED